Cross-Sector entity
Of the tracked stories, 2 of 2 also mention Churchill Downs Incorporated, the most common co-covered peer. Coverage clusters in earnings, which accounts for 1 of those 2, with the remainder spread across 1 other category. Each carries 3 original sources on average.
2 verified stories tracked
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 2 of 2 also mention Churchill Downs Incorporated, the most common co-covered peer. Coverage clusters in earnings, which accounts for 1 of those 2, with the remainder spread across 1 other category. Each carries 3 original sources on average. We currently track 2 Cross-Sector stories that mention GoodRx Holdings, Inc., all published on February 26, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering GoodRx Holdings, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Churchill Downs, GoodRx, and Schrödinger released their 2025 fourth-quarter and full-year financial results, highlighting a year of strategic expansion in gaming, healthcare technology, and AI-driven drug discovery. The reports reflect a broader market trend of resilient consumer spending in entertainment and the increasing integration of software-as-a-service (SaaS) models in specialized industries.
GoodRx reported Q4 2025 sales that exceeded market expectations, yet shares fell nearly 12% as investors weighed future guidance and margin pressures. Meanwhile, Schrödinger is pivoting toward a hosted platform model, targeting 10-15% growth in annual contract value for its computational drug discovery suite.
Source: markets.businessinsider.com · pharmiweb.com
